Скачать или смотреть Should I invest in Inovio Pharmaceuticals 📈📉

If you enjoyed this clip, watch the full video:    • Is Inovio Pharmaceuticals, Inc. Worth Inve...  

Full Playlist:    • Stock Market Investing  

Becoming Ritchie Rich is a new show that takes a deep dive into various penny stocks. If you are someone who wants to learn about the stock market or trades penny stocks, this show is for you. Join me as we do some deep analysis of a popular penny stock. Feel free to ask questions, give suggestions, and share penny stocks you'd like me to take a look at next. Today's popular penny stock is Inovio Pharmaceuticals (INO).

The Investing Bloog Room:
https://www.bloogspace.com/investingb...

More About INO:
Inovio Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from human papillomavirus (HPV)-related diseases, cancer, and infectious diseases. The Company’s lead candidates are focused on diseases associated with HPV. Its DNA medicines pipeline includes INO-3107 for HPV-related Recurrent Respiratory Papillomatosis (RRP), VGX-3100 for the treatment of HPV-related Cervical HSIL, INO-5401 for the treatment of Glioblastoma Multiforme (GBM), INO-5151 (INO-5150 + INO-9012) for the treatment of Prostate Cancer, INO-4800 for COVID-19, INO-4201 for Ebola Virus Disease, INO-4700 for Middle East Respiratory Syndrome (MERS) and INO-4500 for Lassa Fever. Its DNA medicine platform consists of DNA plasmids and its investigational smart device, CELLECTRA, which is used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of three models.

INO Financial Summary:
Inovio Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 40.65 million compared to USD 79.07 million a year ago. Basic loss per share from continuing operations was USD 0.16 compared to USD 0.36 a year ago. Diluted loss per share from continuing operations was USD 0.16 compared to USD 0.36 a year ago.

About the Host:
Ritchie "Rick Da Don" Knox is a serial entrepreneur, investor, media personality, musician, artist, and philanthropist from Detroit, Michigan (USA).

Rick's Companies and Ventures:
1) VidMondo - http://VidMondo.com
2) The Really Hood Podcast - https://open.spotify.com/show/68pNdNZ...
3) FrameTangles - https://opensea.io/collection/frameta...
4) Really Hood - http://ReallyHood.com
5) Rick Da Don Music - http://RickDaDon.com
6) Broken Heart Shirts - http://BrokenHeartShirts.com
7) Weerdy - http://Weerdy.com
8) My Art - http://RitchieKnoxArt.com
9) BloogSpace - https://BloogSpace.com
10) The Rick Da Don Podcast: https://open.spotify.com/show/6Cwv3VK...

Disclaimer:
Becoming Ritchie Rich's host Ritchie Rich is not a financial advisor. This show is created purely for entertainment purposes. Before buying into any position, please DO YOUR OWN RESEARCH.

#Investing #investinginmyfuture #investinginmyself #InvestingInRealEstate #investinginme #investingbooks #investingquotes #investingeducation #investingforus #investinginyourself #InvestInGold #investingstrategy #investinginyourhealth #investinginthefuture #investingwordsofwisdom #investinginyourpeople #investingtips #investingwithjg #investingplanning #Investingnetworkclub #INVESTINGINHISTORY #investingabroad #investinghana #investinginhumanpotential #investingday #InvestingForU #investingourself #investingforwealth #investingolnetworkmarketing #investingnoob

Thanks for LIKING, SHARING, and COMMENTING on this video!